Time to manage Mycoplasma genitalium as an STI: But not with azithromycin 1 g!

Current Opinion in Infectious Diseases

Volumn 27, Issue 1, 2014, Pages 68-74

  Horner, Patrick ^a,b   Blee, Karla ^b   Adams, Elisabeth ^a,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c AQUARIUS POPULATION HEALTH   (United Kingdom)

Author keywords

azithromycin; cervicitis; Mycoplasma genitalium; nongonococcal urethritis; pelvic inflammatory disease

Indexed keywords

AZITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL CLEARANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE GENITAL TRACT INFECTION; MASS SCREENING; MOLECULAR DIAGNOSIS; MYCOPLASMA GENITALIUM INFECTION; NONSPECIFIC URETHRITIS; NUCLEIC ACID AMPLIFICATION; PELVIC INFLAMMATORY DISEASE; REVIEW; SEXUALLY TRANSMITTED DISEASE; URETHRITIS; UTERINE CERVICITIS; VIRUS TRANSMISSION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; COST OF ILLNESS; DISEASE MANAGEMENT; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 84891835202     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000030     Document Type: Review

References (53)

1. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24:498-514.
2. Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 2011; 53 (suppl 3):129-142.
3. McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog 2011; 7:e1001324.
4. McGowin CL, Annan RS, Quayle AJ, et al. Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun 2012; 80:3842-3849.
5. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol 2012; 206:476-478.
6. Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic. PLoS One 2013; 8:e61481.
7. Chrisment D, Charron A, Cazanave C, et al. Detection of macrolide resistance in Mycoplasma genitalium in France. J Antimicrob Chemother 2012; 67:2598-2601.
8. Gesink DC, Mulvad G, Montgomery-Andersen R, et al. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int J Circumpolar Health 2012; 71:1-8.
9. Manhart LE, Khosropour CM, Gillespie CW, et al. Treatment outcomes for persistent Mycoplasma genitalium-associated NGU: evidence of moxifloxacin treatment failures [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A29.
10. Pond MJ, Nori A, Witney AA, et al. Mycoplasma genitalium is as frequent a cause of urethritis as Chlamydia trachomatis, and has high rates of genotypic resistance to macrolide antibiotics [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A63.
11. Tagg KA, Jeoffreys NJ, Couldwell DL, et al. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol 2013; 51:2245-2249.
12. Totten PA, Jensen NL, Khosopour CM, et al. Azithromycin and doxycycline resistance profiles of Mycoplasma genitalium and association with treatment outcomes [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A62.
13. Twin J, Jensen JS, Bradshaw CS, et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One 2012; 7:e35593.
14. Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-a randomized clinical trial. Clin Infect Dis 2011; 52:163-170.
15. Manhart LE, Gillespie CW, Lowens MS, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 2013; 56:934-942.
16. Shimada Y, Deguchi T, Nakane K, et al. Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg Infect Dis 2011; 17:1148-1150.
17. Ison CA. Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment. Curr Opin Infect Dis 2012; 25:73-78.
18. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62:1094-1156. (Pubitemid 28558294)
19. Walker J, Fairley CK, Bradshaw CS, et al. The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women. BMC Infect Dis 2011; 11:35.
20. Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in women the 'New Chlamydia?' A community-based prospective cohort study. Clin Infect Dis 2010; 51:1160-1166.
21. Manhart LE, Holmes KK, Hughes JP, et al. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health 2007; 97:1118-1125. (Pubitemid 351181938)
22. Andersen B, Sokolowski I, Ostergaard L, et al. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect 2007; 83:237-241. (Pubitemid 46999194)
23. Hancock EB, Manhart LE, Nelson SJ, et al. Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women. Sex Transm Dis 2010; 37:777-783.
24. Leung A, Eastick K, Haddon L, et al. Mycoplasma genitalium is associated with symptomatic urethritis. Int J STD AIDS 2006; 17:285-288. (Pubitemid 43668164)
25. Soni S, Alexander S, Verlander N, et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect 2010; 86:21-24.
26. Bradshaw CS, Fairley CK, Lister NA, et al. Mycoplasma genitalium in men who have sex with men at male-only saunas. Sex TransmInfect 2009; 85:432-435.
27. Reinton N, Moi H, Olsen AO, et al. Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men. Sex Health 2013; 10:199-208.
28. Moi H, Ringvik S, Moghaddam A, et al. High burden of extra-genital Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex, especially in HIV-positive. Sex Transm Infect 2013; 89 (Suppl 1):A194.
29. Cosentino LA, Campbell T, Jett A, et al. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol 2012; 50:2005-2008.
30. Edlund M, Blaxhult A, Bratt G. The spread of Mycoplasma genitalium among men who have sex with men. Int J STD AIDS 2012; 23:455-456.
31. Horner PJ. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex Transm Infect 2012; 88:154-156.
32. Amsden GW. Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 1996; 18:56-72.
33. Twin J, Bradshaw C, Garland S, et al. Mycoplasma genitalium infectious load and treatment failure due to selected macrolide resistance [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A66-A67.
34. Wiesenfeld HC, Hillier SL, Meyn L, et al. Mycoplasma genitalium: is it a pathogen in acute pelvic inflammatory disease (PID)? [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A34.
35. Bjartling C, Osser S, Persson K. Mycoplasma genitalium and Chlamydia trachomatis in laparoscopically diagnosed pelvic inflammatory disease [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A15.
36. Bradshaw CS, Tabrizi SN, Read TRH, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193:336-345. (Pubitemid 43122332)
37. Ito S, Tsuchiya T, Yasuda M, et al. Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years-of-age with acute epididymitis. Int J Urol 2012; 19:234-238.
38. Manhart LE. Another STI associated with HIV-1 acquisition: now what? AIDS 2012; 26:635-637.
39. Mavedzenge SN, Van Der Pol B, Weiss HA, et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS 2012; 26:617-624.
40. Vandepitte J, Muller E, Bukenya J, et al. Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis 2012; 205:289-296.
41. Le Roy C, Pereyre S, Bebear C. Evaluation of two commercial real-time PCR assays for detection of Mycoplasma genitalium in urogenital specimens [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A102-A103.
42. Le Roy C, Le Hen I, ClercM, et al. The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J Microbiol Methods 2012; 89:193-197.
43. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, In the published guideline Capitols are used for "Sexually Transmitted Diseases Treatment Guidlines." 2010. MMWR 2010; 59 (RR12):1-110; http://www.cdc.gov/std/treatment/2010/STD-Treatment-2010- RR5912.pdf. [Accessed 25 November 2013]
44. Ross JDC, McCarthy G, Clinical Effectiveness Group BASHH. UK National Guideline for the Management of Pelvic Inflammatory Disease 2011. London: British Association for Sexual Health and HIV; 2011; http://www.bashh.org/ documents/3572.pdf. [Accessed 25 November 2013]
45. Public Health England. Table 5: Number of STI diagnoses and services in England, 2002-2011. http://www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/STIs/STIsAnnualDataTables/. [Accessed 25 November 2013]
46. Sena AC, Lensing S, Rompalo A, et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis 2012; 206:357-365.
47. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19:676-679.
48. Terada M, Izumi K, Ohki E, et al. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. J Infect Chemother 2012; 18:313-317.
49. Savaris RF, Teixeira LM, Torres TG, et al. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol 2007; 110:53-60. (Pubitemid 47015700)
50. Bevan CD, Ridgway GL, Rothermel CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res 2003; 31:45-54. (Pubitemid 36335875)
51. Horner P. Recurrent and persistent urethritis in men: a structured evidence based approach to management [abstract]. Sex Transm Infect 2013; 89 (Suppl 1):A23.
52. Gaydos CA, Van Der Pol B, Goheen M, et al. Performance of the Cepheid CT/NG Xpert Rapid PCR test for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2013; 51:1666-1672.
53. Peuchant O, Duvert JP, Clerc M, et al. Effects of antibiotics on Chlamydia trachomatis viability as determined by real-time quantitative PCR. J Med Microbiol 2011; 60:508-514.